Advanced glycation end-products diminish tendon collagen fiber sliding.
Connective tissue aging and diabetes related comorbidity are associated with compromised tissue function, increased susceptibility to injury, and reduced healing capacity. This has been partly attributed to collagen cross-linking by advanced glycation end-products (AGEs) that accumulate with both age and disease. While such cross-links are believed to alter the physical properties of collagen structures and tissue behavior, existing data relating AGEs to tendon mechanics is contradictory. In this study, we utilized a rat tail tendon model to quantify the micro-mechanical repercussion of AGEs at the collagen fiber-level. Individual tendon fascicles were incubated with methylglyoxal (MGO), a naturally occurring metabolite known to form AGEs. After incubation in MGO solution or buffer only, tendons were stretched on the stage of a multiphoton confocal microscope and individual collagen fiber stretch and relative fiber sliding were quantified. Treatment by MGO yielded increased fluorescence and elevated denaturation temperatures as found in normally aged tissue, confirming formation of AGEs and related cross-links. No apparent ultrastructural changes were noted in transmission electron micrographs of cross-linked fibrils. MGO treatment strongly reduced tissue stress relaxation (p<0.01), with concomitantly increased tissue yield stress (p<0.01) and ultimate failure stress (p=0.036). MGO did not affect tangential modulus in the linear part of the stress-strain curve (p=0.46). Microscopic analysis of collagen fiber kinematics yielded striking results, with MGO treatment drastically reducing fiber-sliding (p<0.01) with a compensatory increase in fiber-stretch (p<0.01). We thus conclude that the main mechanical effect of AGEs is a loss of tissue viscoelasticity driven by matrix-level loss of fiber-fiber sliding. This has potentially important implications to tissue damage accumulation, mechanically regulated cell signaling, and matrix remodeling. It further highlights the importance of assessing viscoelasticity - not only elastic response - when considering age-related changes in the tendon matrix and connective tissue in general.
Department of Orthopaedics, Balgrist Hospital, University of Zurich, Switzerland.
Yufei
Y
Li
Gion
G
Fessel
Marios
M
Georgiadis
Jess G
JG
Snedeker
D000375:Aging; D000818:Animals; D001696:Biomechanical Phenomena; D055119:Elastic Modulus; D005109:Extracellular Matrix / Q000502:physiology / Q000648:ultrastructure; D024022:Fibrillar Collagens / Q000648:ultrastructure; D017127:Glycation End Products, Advanced / Q000494:pharmacology / Q000502:physiology*; D066298:In Vitro Techniques; D011765:Pyruvaldehyde / Q000494:pharmacology; D051381:Rats; D013312:Stress, Physiological; D013710:Tendons / Q000502:physiology* / Q000648:ultrastructure; D044366:Transition Temperature; D014783:Viscosity
D024022:Fibrillar Collagens; D017127:Glycation End Products, Advanced; D011765:Pyruvaldehyde